Carbon Biosciences is the first company to publicly launch from the Foundation’s collaboration with Longwood Fund and the first to work alongside CF Foundation researchers at the Foundation’s therapeutics lab
Site Search
Showing 21 - 23 of 23 results
Press Release
|
July 15, 2021
|
2 min read
Press Release
|
June 21, 2022
|
4 min read
Prime Medicine’s prime editing technology has the potential to bring genetic therapies to all people with cystic fibrosis, ultimately paving the way to a cure.
Press Release
|
Jan. 25, 2024
|
4 min read